OTF
ACAD icon

Opus Trading Fund’s Acadia Pharmaceuticals ACAD Stock Holding History

Opus Trading Fund’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$250K Buy
+13,800
New +$190K 0.48% 29

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Opus Trading Fund's ACAD Position: Q2 2013 in Review

Opus Trading Fund opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2013: 13,800 shares worth $250K. The stake represents 0.48% of the portfolio and ranks #29 among its holdings.

123 funds tracked by Wall St. Rank hold ACAD as of Q2 2013.

  • Opus Trading Fund held 13,800 shares of Acadia Pharmaceuticals worth $250K as of Q2 2013.
  • Acadia Pharmaceuticals was a new Opus Trading Fund position in Q2 2013.
  • Acadia Pharmaceuticals made up 0.48% of Opus Trading Fund's portfolio in Q2 2013, its #29 holding.
  • 123 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2013.

Based on Opus Trading Fund's 13F filing for Q2 2013, filed 5 Aug 2013.